Spyre Therapeutics (SYRE) Debt Ratio (2023 - 2025)
Historic Debt Ratio for Spyre Therapeutics (SYRE) over the last 3 years, with Q3 2025 value amounting to 0.02.
- Spyre Therapeutics' Debt Ratio fell 6282.89% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 6282.89%. This contributed to the annual value of 0.04 for FY2024, which is 91370.27% up from last year.
- According to the latest figures from Q3 2025, Spyre Therapeutics' Debt Ratio is 0.02, which was down 6282.89% from 0.11 recorded in Q2 2025.
- Over the past 5 years, Spyre Therapeutics' Debt Ratio peaked at 0.67 during Q2 2023, and registered a low of 0.0 during Q4 2023.
- Over the past 3 years, Spyre Therapeutics' median Debt Ratio value was 0.04 (recorded in 2024), while the average stood at 0.1.
- As far as peak fluctuations go, Spyre Therapeutics' Debt Ratio tumbled by 9910.31% in 2024, and later skyrocketed by 173621.16% in 2025.
- Spyre Therapeutics' Debt Ratio (Quarter) stood at 0.0 in 2023, then surged by 913.7% to 0.04 in 2024, then tumbled by 47.02% to 0.02 in 2025.
- Its Debt Ratio stands at 0.02 for Q3 2025, versus 0.11 for Q2 2025 and 0.08 for Q1 2025.